Recombinant Human CELF2 Protein, N-His from ProteoGenix; catalogue ARO-P12070; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human CELF2 Protein, also known as CUGBP, Elav-like family member 2, is a protein that plays a crucial role in RNA processing and regulation of gene expression. It is a member of the CELF family of RNA-binding proteins, which are known to be involved in various cellular processes such as cell differentiation, proliferation, and apoptosis.
The Recombinant Human CELF2 Protein is a 62 kDa protein consisting of 522 amino acids. It contains three RNA recognition motifs (RRMs) that are responsible for binding to specific RNA sequences. These motifs are highly conserved among CELF family members and are essential for their function.
In addition to the RRMs, Recombinant Human CELF2 Protein also contains a nuclear localization signal, a nuclear export signal, and a serine-rich domain. These domains play a crucial role in the subcellular localization and function of the protein.
Recombinant Human CELF2 Protein is primarily involved in the regulation of RNA processing. It binds to specific RNA sequences and regulates their splicing, polyadenylation, and translation. This, in turn, affects the expression of various genes and ultimately impacts cellular processes.
One of the key functions of Recombinant Human CELF2 Protein is its role in alternative splicing. It has been shown to regulate the splicing of numerous pre-mRNAs, including those involved in muscle development, neuronal differentiation, and immune response. By binding to specific RNA sequences, Recombinant Human CELF2 Protein can either promote or repress splicing, thereby regulating the production of different protein isoforms.
Recombinant Human CELF2 Protein also plays a crucial role in the regulation of mRNA stability. It has been shown to bind to the 3′ untranslated region (UTR) of target mRNAs and regulate their stability. This, in turn, affects the amount of protein produced from these mRNAs and can have a significant impact on cellular function.
Due to its important role in RNA processing and gene expression, Recombinant Human CELF2 Protein has been studied extensively in various fields of research. One of the major applications of this protein is in the field of cancer research.
Aberrant splicing has been linked to several types of cancer, and Recombinant Human CELF2 Protein has been shown to regulate the splicing of genes involved in cancer progression. This makes it a potential target for cancer therapy and a valuable tool for studying the mechanisms of cancer development.
Recombinant Human CELF2 Protein has also been implicated in various neurological disorders. It has been shown to play a role in neuronal differentiation and survival, and its dysregulation has been linked to neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Therefore, understanding the function of this protein could provide valuable insights into these disorders and potentially lead to the development of new treatments.
In addition, Recombinant Human CELF2 Protein has been studied in the context of muscle development and heart disease. It has been shown to regulate the splicing of genes involved in muscle differentiation, and its dysregulation has been linked to cardiac hypertrophy and heart failure. Therefore, Recombinant Human CELF2 Protein could be a potential therapeutic target for these conditions.
Recombinant Human CELF2 Protein is a crucial protein involved in RNA processing and gene expression. Its structure, activity, and applications have been extensively studied, and it has been shown to play a critical role in various cellular processes. Understanding the function of this protein could have significant implications in the fields of cancer research, neurodegener
ProteoGenix catalogue number ARO-P12070. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 21.56 kDa; Fragment: Lys41-Asp211; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
